XLRN
Acceleron Pharma Inc.
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
270 hedge funds and large institutions have $6.72B invested in Acceleron Pharma Inc. in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 83 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
270
Holders Change
+15
Holders Change %
+5.88%
% of All Funds
4.71%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.16%
New
43
Increased
90
Reduced
83
Closed
28
Calls
$24.9M
Puts
$43.9M
Net Calls
-$19M
Net Calls Change
-$7.93M
Top Buyers
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$352M |
| 2 |
2
Alkeon Capital Management
New York
|
$157M |
| 3 |
3
Goldman Sachs
New York
|
$14.7M |
| 4 |
4
BlackRock
New York
|
$553M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$616M |
